Skip to content
Off-topic for aiqbench

Off-topic for aiqbench

This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.

Tavexia Lifecare to acquire 60% of Meyonex Pharmaceuticals for $8M

Dealroom.co1 min read

Tavexia Lifecare to acquire 60% of Meyonex Pharmaceuticals for $8M  Dealroom

Read the full article at Dealroom.co

Related coverage